Search results for: Consulting Reports
Filter search results
OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?
16 January 2020
…has written numerous books, articles and reports in this area on a wide range of subjects. He has been involved in a number of major clinical trials as the lead…
Let’s talk about (health) inequalities
1 April 2022
…Cavill, Parker and Hammond (2020) adapted from Public Health Scotland (2021) How should ‘Health Inequalities’ be tackled? Fortunately, both reports (‘ NICE Listens’ and ‘ Attitudes to Inequalities’) showed that…
Accounting for Preference Heterogeneity in Discrete Choice Experiments
4 May 2022
…collaboration between members of the ISPOR Health Preference Research Special Interest Group, reports the results of a literature review and an expert survey. What are discrete choice experiments (DCEs)? DCEs…
What is the Role of HTA for Biosimilars?
1 April 2014
…for biosimilars in the UK. It reports on the roundtable’s deliberations about when HTA for biosimilars is needed and which approaches are most appropriate in specific situations. The roundtable’s caution…
Report of the Office of Health Economics Commission on Competition in the NHS
1 January 2012
…commissioned three background reports, available for download below. Download Forder, G. and Allan, S., 2011. Competition in the care homes market. Report for the OHE Commission on Competition in the…
Using Happiness to Value Health
1 November 2011
…people are asked about their preferences. In particular, mental health matters more in happiness reports. One implication of using happiness to value health, then, might be that greater priority would…
Managing Poorly Performing Clinicians: The Value of Independent Help
1 March 2011
…the NCAS is to become self-funding. This Research Paper reports on a project meant to establish how much referrers in the NHS value NCAS’s services and the relative value placed…
Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
9 January 2009
…may be particularly important in the pharmaceutical and biotech sectors because of the characteristics of that R&D, including high uncertainty, high rates of failure and high costs. The study reports…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
…decisions about research and development in the biopharmaceutical industries. This Briefing reports on the results of a survey of 19 pharmaceutical and biotechnology companies, a sample sufficient to provide an…